Every clinician has a calculator app on their phone, most of us have two, and the category has been quietly stable for a decade. Here's an honest look at the tools people actually open on shift — none of them ours, no ranking, no winner. Ratings and figures below are from public app-store listings and the developers' own pages, linked inline, as of July 2026.
MDCalc
The default, and deservedly. MDCalc offers 270+ clinical decision tools — scores, equations, algorithms, dosing — free on iOS and Android, and its Android listing shows a 4.9-star rating with over a million downloads (Google Play, via library guide listings). MDCalc's own about page cites survey data that a large majority of US attendings and residents use it regularly (MDCalc) — a vendor-cited figure, but consistent with what you see in any physician workroom.
What makes it the benchmark isn't the math — every app computes a HEART score identically — it's the editorial layer: inclusion criteria, pitfalls, the original paper, and "next steps" guidance attached to every score, much of it written and reviewed by clinicians. When you half-remember whether PERC applies to your patient, that surrounding text is the product.
Calculate by QxMD
The veteran alternative, with 400+ calculators and decision tools (App Store), rated about 4.5 stars from roughly 13,000 ratings on Android (AppBrain). Calculate's distinctive strength is its question-flow design — it walks you through inputs conversationally rather than presenting a form — and its integration with QxMD's Read literature app, which keeps the score attached to the evidence. Owned by WebMD/Internet Brands, it has stayed free and stayed maintained.
The rest of the field
- Merck Manual Professional (free, iOS/Android) bundles calculators inside a full reference — weaker as a pure calculator, strong when you want the disease context one tap away.
- Institutional favorites — UpToDate's embedded calculators and Epocrates' dosing tools — win on being already open, not on being better calculators.
- Specialty one-offs (ASCVD Risk Estimator Plus from the ACC, dedicated anticoagulation and nephrology apps) remain the right answer when a society maintains the definitive version of its own score.
What they all still make you do
Here is the category's shared, decade-old limitation: every one of these apps makes you re-type data the chart already knows. Same patient, five scores, and you enter the creatinine five times — once each for the eGFR, the MELD, the FENa, the anticoagulation decision, and the contrast-risk check. The apps are context-free by design: they don't know your patient, so every calculation starts from a blank form, and the result lives in the app rather than in your note, where a colleague could actually see your reasoning.
That's not a criticism of the developers — it's an architectural boundary. A standalone app can't see the chart, and probably shouldn't. But it explains the category's next decade: the interesting question is no longer "which app has the most calculators" (the math is commoditized and mostly public-domain formulas) but "when does the calculation move to where the data already is." EHR vendors, scribe vendors, and the calculator apps themselves are all circling that question from different directions. Expect the answer to involve pre-filled inputs a clinician confirms — not auto-computed scores, which would trade re-typing for a subtler and worse error mode.
Until then: MDCalc if you want the editorial depth, Calculate if you prefer the guided flow, and there is no wrong answer between them. Both are free; carry both.
Pulse is tebIQ's news hub — more tool reviews and clinical AI coverage at tebiq.com.